Cargando…
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative viral pathogen of coronavirus disease 2019 (COVID-19), appears to have various clinical presentations and may result in severe respiratory failure. The global SARS-CoV-2-associated viral pneumonia pandemic was first reported...
Autores principales: | Yang, Chih-Jen, Wei, Yu-Jui, Chang, Hsu-Liang, Chang, Pi-Yu, Tsai, Chung-Chen, Chen, Yen-Hsu, Hsueh, Po-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534785/ https://www.ncbi.nlm.nih.gov/pubmed/33060041 http://dx.doi.org/10.1016/j.jmii.2020.09.002 |
Ejemplares similares
-
EGFR Tyrosine Kinase Inhibitor–Associated Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
por: Chang, Hsu-Liang, et al.
Publicado: (2020) -
Cardiovascular disease management during the coronavirus disease 2019 pandemic
por: Lee, Wen-Hsien, et al.
Publicado: (2020) -
Precaution and prevention of coronavirus disease 2019 infection in the eye
por: Chen, Meng-Jou, et al.
Publicado: (2020) -
Management of Hyperacute Stroke during the Coronavirus Disease of 2019 Pandemic: The Modified Code Stroke in a Medical Center in Taiwan
por: Lin, Po-Yu, et al.
Publicado: (2020) -
Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)